Cannabis Science Inc (OTCMKTS:CBIS) reported that its in-house lab is nearly complete. The company has commenced clinical advancement plans to commence working with its associate IGXBio, Inc. to advance effective cannabinoid therapeutics utilizing IGXBio’s Immunotherapy FDA IND.
Dr. Allen Herman, the Chief Medical Officer of Cannabis Science, said that again they are looking to cement their foothold in the considerable pharmaceutical drug advancement industry. They anticipate IGXBio, GenePro® drug advancement plan to turn into a major pharmaceutical success. Along with property development contracts, the company is acquiring the required land base to source a key countrywide pharmaceutical demand. The program specifics are in progress and the management will update results and progress as they come in.
GenePro® can be stated as an investigational DNA immunotherapy funded by IGXBio. The Cannabis Science association is working to identify and advance and GenePro® and agonist cannabinoids. GenePro® is a DNA plasmid vaccine expressing SIV and HIV proteins, which is given by electroporation. This FDA IND backs a device and biologic combination product.
HIV utilizes immune system to pollute healthy immunogenic cells and intensify the prospect of these cells to increase. HIV-1 proteins are released from infested cells during the course of infection and make a continuing HIV disease burden in numerous tissues, including the CNS, resulting in damage and toxicity, irrespective of ART.
A considerable number of persons with HIV disease undergo brain impairment. A number of standard anti-retroviral medications cannot move beyond the blood-brain barrier and hence they have no impact on HIV infection in the brain.
Singlepoint Inc (OTCMKTS:SING)Expands Partnership with RedFynn Technologies
Pivoting from their initial deal, RedFynn and SinglePoint will continue their association and introduce SinglePoint’s offerings to more United Way branches and charities. Moreover, RedFynn will offer company with access to mine its over 150,000 customer accounts to launch its mobile payment goods to new viewers in the non-profit industry.
Greg Lambrecht, the CEO, said that they are confident that Mesa United Way makes one of the many valued deals and business associations that will come from their association with RedFynn. As they continue to leverage this deal and advance growth plans, they are assured that they can post considerable revenue prospects from this fresh sales channel.